Congress Coverage: ASH 2021 – Focus on Leukemia
Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making regarding leukemia.
Faculty Co-Chair
Elias Jabbour, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Faculty Co-Chair
Nicola Gökbuget, MD
Goethe University Hospital, Frankfurt, Germany
Faculty Members
Naval Daver, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Guillermo Garcia-Manero, MD
The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Jae Park, MD
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Amir Fathi, MD
Massachusetts General Hospital, Boston, MA, USA
Josep-Maria Ribera, MD, PhD
Hospital Universitari Germans Trias i Pujol, Barcelona, Spain
Charles Craddock, CBE, FRCP (UK), FRCPath, DPhil, FMedSci
Queen Elizabeth Hospital, Birmingham, United Kingdom
Valeria Santini, MD
University of Florence, Firenze, Italy
REPORT SNAPSHOT
The report was based on the following topics
- New Developments in MDS
- Advances in AML: Newly Diagnosed
- Advances in AML: Relapsed/Refractory
- Advances in ALL: Newly Diagnosed
- Advances in ALL: Relapsed/Refractory
